Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00723762 · ClinicalTrials.gov registry record
Valproic Acid-associated Hypoalbuminemia in Medically Fragile Patients
A clinical trial, sponsored by Akron Children's Hospital.
- Completed
- Registry status
- 90
- Enrollment target
NCT00723762: Completed study, sponsored by Akron Children's Hospital.
NCT00723762 is a clinical trial that has completed, run by Akron Children's Hospital. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00723762 has completed, sponsored by Akron Children's Hospital.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate potential mechanisms of valproic acid-associated low serum albumin in medically fragile pediatric and young adult epileptic patients of a long-term care facility.
Interventions
- PROCEDURE Specimen collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-12 |
What the finished NCT00723762 record still lists
NCT00723762 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Specimen collection is the first listed.
NCT00723762 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00723762 about?
NCT00723762 is a clinical study titled "Valproic Acid-associated Hypoalbuminemia in Medically Fragile Patients". The purpose of this study is to investigate potential mechanisms of valproic acid-associated low serum albumin in medically fragile pediatric and young adult epileptic patients of a long-term care facility.
What is the current status of trial NCT00723762?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2009-02. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00723762?
The interventions under investigation include: Specimen collection (PROCEDURE).
Who is sponsoring clinical trial NCT00723762?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia